Frontotemporal Dementia

This is a type of dementia that affects the front and side parts of the brain. It causes changes in personality, behavior, and thinking skills. People might become more impulsive, lose interest in things, or have trouble with planning and speaking.

Condition

What people with Frontotemporal Dementia report

Every report comes from a Lived member, sent anonymously.

Have you tried Speech therapy for Frontotemporal Dementia?

NameHow it went

About Frontotemporal Dementia

What It Is

Frontotemporal dementia (FTD) is a group of brain diseases in which nerve cells in the frontal and temporal lobes, the parts of the brain behind the forehead and above the ears, gradually stop working and die. These areas handle planning, judgment, social behavior, emotion and language, so FTD usually first shows up as changes in personality, behavior or speech rather than forgetfulness. It was once called Pick's disease, and doctors may also use the terms frontotemporal degeneration or frontotemporal disorders. The most common form, behavioral variant FTD, changes how a person acts. Someone may become impulsive or socially inappropriate, lose interest in family and activities, seem to lack empathy, repeat the same actions, or eat compulsively. In another form, primary progressive aphasia, language goes first: a person may lose the meaning of familiar words or struggle to put sentences together. Some people develop movement problems such as stiffness, falls and trouble swallowing, and a smaller group has FTD together with ALS (amyotrophic lateral sclerosis), which causes progressive muscle weakness. FTD tends to begin earlier than other dementias. Roughly 60% of people with it are between 45 and 64, often while they are still working and raising families.

Causes & Risk Factors

In most people, the cause of FTD is unknown. In the affected brain areas, proteins called tau and TDP-43, which normally help cells work, behave abnormally and the nerve cells are damaged. Why this begins is not yet understood. Genetics play a larger role than in most dementias. An estimated one-third of cases are inherited, passed from parent to child through a variant in a single gene. The best known are MAPT, GRN and C9orf72. A MAPT variant almost always leads to the disease, although the age it starts cannot be predicted, and a C9orf72 variant can cause FTD, ALS or both, even within the same family. These variants can often be identified with genetic testing. A family history of FTD, or of FTD and ALS together, is the main clue that a genetic cause may be involved. Researchers are also studying environmental factors, but none has been established.

How It's Diagnosed

FTD is often hard to recognize at first. Because the early changes are in behavior and personality, it is frequently mistaken for depression or another mental health condition, and it can also be confused with Alzheimer's disease. The person often does not notice the changes in themselves, so reports from family and friends are especially important. A neurologist or memory specialist reviews symptoms and personal and family history, examines the person, and uses tests of behavior, memory, thinking, language and movement. Blood tests help rule out other causes. An MRI scan can show shrinking of the frontal and temporal lobes and rule out a stroke or tumor, though it may look normal early on. A PET scan, which shows how actively different brain regions are working, and tests for Alzheimer's-related changes can help tell FTD from Alzheimer's. A psychiatric evaluation can sort out whether depression is causing or adding to the symptoms. No single test confirms FTD during life except genetic testing in inherited cases. Specialized FTD centers can be valuable because the condition is uncommon and easy to misdiagnose.

Treatment Options

There is currently no cure for FTD and no treatment that slows it down. Treatment aims to ease specific symptoms, keep the person safe and support the family, and it works best with a team that may include a neurologist, nurses, social workers and speech, physical and occupational therapists. For behavior changes, antidepressants called selective serotonin reuptake inhibitors (SSRIs), and trazodone, a related antidepressant, can reduce disinhibition, compulsive behaviors and overeating in some people. They do not improve thinking, and the research behind them is limited, so finding a helpful medicine can involve trial and adjustment. Low doses of antipsychotic medicines are sometimes used for aggression or delusions. These carry real risks, including a higher risk of death in older people with dementia, so they are reserved for symptoms that cause serious distress or danger. The Alzheimer's medicines donepezil (Aricept) and memantine (Namenda) have not helped FTD in studies, and drugs like donepezil can make behavior worse. If one is prescribed, it is worth asking why. Non-drug approaches matter as much as medicine. A predictable routine, fewer distractions, simple choices, and supervision of meals and money can reduce problems in daily life. For language decline, a speech-language therapist experienced with progressive aphasia can teach communication tools such as picture books, gestures and phone apps. For movement problems, physical therapy, walking aids and sometimes Parkinson's medicines can give modest or temporary relief. Clinical trials are testing treatments aimed at the underlying disease, especially in inherited forms.

What to Expect

FTD gets worse over time, and the pace varies widely. People typically live six to eight years after diagnosis, though some live more than ten years and others less than two. The form with ALS usually progresses faster, over two to three years. Early on, a person may have only one type of symptom; as more of the brain is affected, behavior, language and movement problems tend to overlap and the person needs more supervision and care. The behavior changes are often the hardest part for families. The person usually cannot control these behaviors and may not recognize them, so arguing or reasoning rarely helps; responding calmly and adjusting the environment usually works better. Work is often affected early, and job loss is common. In the US, FTD qualifies for faster Social Security disability review through the Compassionate Allowances program. Planning early is important because judgment and the ability to make decisions decline. Updating a will, a living will and durable powers of attorney for health care and finances soon after diagnosis lets the person take part, and over time it may become necessary to limit their access to money. Like other dementias, FTD can lead to wandering; door alarms, out-of-sight locks and a GPS device can reduce the risk. Caregivers often see their own health suffer. Respite care, adult day programs and FTD-specific support groups can help, and many families eventually need home care or a residential care setting. In the late stages, swallowing problems and falls become the main dangers, and pneumonia from food or fluid entering the lungs can be fatal.

When to Seek Help

Arrange an evaluation when someone, especially in midlife, shows a lasting change in personality, judgment, social behavior or language, even if their memory seems fine. A new diagnosis of depression or another psychiatric condition that does not fit, or does not respond to treatment, is worth a second look by a neurologist. Contact the care team promptly about coughing or choking when eating or drinking, frequent falls, aggression that puts anyone at risk, or a sudden change in behavior or alertness, which may signal an infection, medication effect or another illness rather than FTD itself. A missing person with dementia is an emergency: call 911 right away and tell the dispatcher the person has dementia.

Questions to Ask Your Doctor

  1. 1.Which type of FTD does this look like, and how confident are we in the diagnosis compared with Alzheimer's or a psychiatric condition?
  2. 2.Given our family history, should we consider genetic counseling or testing, and what would a result mean for other relatives?
  3. 3.Which symptoms are most worth treating right now, and how will we judge whether a medicine is helping or making things worse?
  4. 4.Which specialists, therapists or FTD centers should be part of the care team, and are there clinical trials we could join?
  5. 5.What legal, financial and care arrangements should we put in place now, while the person can still take part in decisions?

Last reviewed • Oct 2026

Educational content, not medical advice.